MetaCap

Exelixis (EXEL) News

NASDAQ: EXELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

64.63-1.20 (-1.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EXEL news summary

We found 50 recent headlines mentioning Exelixis (EXEL): 6 in the past week and 29 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. For price context, EXEL is down 1.82% at $64.63. The most recent story, "Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?", was published by Nasdaq on Nov 20, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Exelixis headlines

Stocks mentioned alongside EXEL

Compare EXEL